Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
Public ClinicalTrials.gov record NCT07063056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Curcumin and Astaxanthin for Lowering Triglyceride Readings and Inflammation
Study identification
- NCT ID
- NCT07063056
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Medinutra LLC
- Other
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Astaxanthin Dietary Supplement
- Curcumin (Longvida™) Dietary Supplement
- Half Dose Curcumin (Longvida™) Dietary Supplement
- Placebo Control Other
Dietary Supplement · Other
Eligibility (public fields only)
- Age range
- 21 Years to 59 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2025
- Primary completion
- Nov 14, 2025
- Completion
- Nov 30, 2025
- Last update posted
- Jul 31, 2025
2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medinutra LLC | Dublin | Ohio | 43016 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07063056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07063056 live on ClinicalTrials.gov.